IOWA SPECIALTY HOSPITAL - CLARION
1. Target Overview & Investment Thesis
IOWA SPECIALTY HOSPITAL - CLARION is a 25-bed suburban community hospital in WRIGHT, IA with $77.3M in net patient revenue and a 0.2% operating margin. The hospital serves a payer mix of 26.2% Medicare, 5.9% Medicaid, and 67.9% commercial.
Thesis: Turnaround. Our ML models identify $5.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.2% to 7.6% (+736bps).
| Net Revenue HCRIS | $77.3M |
| Current EBITDA COMPUTED | $190K |
| Operating Margin COMPUTED | 0.2% |
| Occupancy HCRIS | 41.8% |
| Revenue / Bed COMPUTED | $3.1M |
| Net-to-Gross HCRIS | 41.2% |
| Distress Probability ML | 48.6% |
2. Market Context & Competitive Position
IA has 124 Medicare-certified hospitals with a median operating margin of -8.2%. The target's margin of 0.2% places it above the state median. Among 93 size-comparable peers (12-50 beds), the median margin is -8.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 93 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| IOWA SPECIALTY HOSPITAL - CLAR (Target) | IA | 25 | $77.3M | 0.2% |
| TRINITY REGIONAL MEDICAL CENTE | IA | 44 | $140.4M | -6.8% |
| PELLA REGIONAL HEALTH CENTER | IA | 25 | $108.8M | -16.6% |
| SPENCER MUNICIPAL HOSPITAL | IA | 49 | $108.7M | -10.3% |
| GREATER REGIONAL MEDICAL CENTE | IA | 25 | $89.4M | -4.4% |
| ST. ANTHONY REGIONAL HOSPITAL | IA | 49 | $84.0M | -21.0% |
| WINNESHIEK MEDICAL CENTER | IA | 25 | $77.6M | -0.1% |
| MAHASKA HEALTH PARTNERSHIP | IA | 25 | $75.6M | -3.9% |
| WAVERLY HEALTH CENTER | IA | 21 | $68.6M | -8.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.5M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $940K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $49K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $190K |
| + RCM Uplift | +$5.7M |
| Pro Forma EBITDA | $5.9M |
| Current Margin | 0.2% |
| Pro Forma Margin | 7.6% |
| WC Released (1x) | $3.0M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $292K | $58.1M | 199.37x | 188.4% |
| Base (11x exit) | 10.0x | 11.0x | $292K | $64.0M | 219.63x | 194.0% |
| Bull Case | 9.0x | 11.0x | $262K | $82.9M | 315.93x | 216.2% |
| Bull (12x exit) | 9.0x | 12.0x | $262K | $90.5M | 344.94x | 221.8% |
| Bear Case | 11.0x | 10.0x | $321K | $29.6M | 92.28x | 147.2% |
| Bear (11x exit) | 11.0x | 11.0x | $321K | $32.7M | 101.83x | 152.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 93 hospitals with 12-50 beds
- Same-state prioritization (n=94)
- Comp margins: P25=-14.6% / P50=-8.4% / P75=-3.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.